| Transvenous biventricular defibrillation. | |
| | |
MedLine Citation:
|
PMID: 11084104 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The recent success of biventricular pacing with transvenously implantable left ventricular leads suggests that left ventricular leads may be useful for other modes of therapy. Animal studies showed small leads inserted into a left ventricular vein dramatically reduced defibrillation strength requirements. This article describes a human investigation of the feasibility of biventricular defibrillation. Fifty-one patients undergoing implantable cardioverter defibrillator (ICD) implantation were enrolled. After insertion of a standard ICD lead, a prototype over-the-wire left ventricular defibrillation lead was inserted through the coronary sinus and into a vein on the left ventricle. Lead insertion was guided by retrograde venography. The left ventricular lead's location was randomized to the anterior or posterior vein. Randomized, paired defibrillation threshold (DFT) testing was performed to compare a standard ICD shock configuration (Control: right ventricle- --> superior vena cava+ + CAN+) to 1 of 3 biventricular shock configurations. In the anterior vein, the left ventricular lead was tested with either a single biphasic shock from right ventricle + left ventricle- --> superior vena cava+ + CAN+ or a dual biphasic shock. In the posterior vein, the left ventricular lead was tested with a dual biphasic shock. Dual shocks consisted of a 40% tilt biphasic shock from right ventricle- --> superior vena cava+ + CAN+ followed by another 40% tilt biphasic shock from left ventricle- --> superior vena cava+ + CAN+, delivered from a single 225 microF capacitance. Left ventricular lead positioning was successful in 41 of 46 patients (89%). Mean left ventricular lead insertion time was 17 +/- 17 minutes and 13 +/- 15 minutes for anterior and posterior locations, respectively. Mean DFTs were not statistically lower for the left ventricular shock configurations, but retrospective analysis showed a well-defined region of the posterolateral left ventricle where consistent DFT reduction was achieved with dual shocks (14.0 +/- 2.7 J vs 7.8 +/- 0.9 J; n = 5; p = 0.04). There were no adverse events requiring intervention due to the use of the left ventricular lead. Biventricular defibrillation is feasible and safe under the conditions used in this study. Additional studies are needed to verify whether dual shocks with posterolateral left ventricular lead positions consistently reduce DFTs. |
| | |
Authors:
|
E Meisel; C Butter; F Philippon; S Higgins; S A Strickberger; J Smith; S Hahn; U Michel; B Schubert; D Pfeiffer |
Related Documents
:
|
9491944 - Cardiogenic shock: therapy and prevention. 18655944 - The use of vasopressors and inotropes in the emergency medical treatment of shock. 7579834 - Myocardial self-preservation: absence of heat shock factor activation and heat shock pr... 9447304 - Cardiogenic shock: 'going to the mat'--is it needed and does it work? 7498194 - False diagnosis of myocardial infarction due to an extreme left sided cardiac rotation ... 17671524 - A case of acute ischemic stroke: optimizing management with penumbra and vessel imaging. |
Publication Detail:
|
Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The American journal of cardiology Volume: 86 ISSN: 0002-9149 ISO Abbreviation: Am. J. Cardiol. Publication Date: 2000 Nov |
Date Detail:
|
Created Date: 2005-11-04 Completed Date: 2005-12-20 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 76K-85K Citation Subset: AIM; IM |
Affiliation:
|
Heart and Circulation Center, Dresden, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Coronary Vessels Defibrillators, Implantable* Electric Countershock / instrumentation*, methods Electrodes, Implanted Feasibility Studies Female Humans Male Middle Aged Prospective Studies Tachycardia, Ventricular / therapy* Veins Ventricular Fibrillation / therapy* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Optimal method to achieve consistently low defibrillation energy requirements.
Next Document: Current status of dual-sensor pacemaker systems for correction of chronotropic incompetence.